Effects of prolonged application of isoprenaline on intracellular free magnesium concentration in isolated heart of rat.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 2175690)

Published in Br J Pharmacol on June 01, 1993

Authors

H Nishimura1, T Matsubara, Y Ikoma, S Nakayama, N Sakamoto

Author Affiliations

1: Department of Internal Medicine III, School of Medicine, Nagoya University, Japan.

Articles cited by this

Determination of intracellular pH by 31P magnetic resonance. J Biol Chem (1973) 6.71

Effects of magnesium on contractile activation of skinned cardiac cells. J Physiol (1975) 3.47

Calcium-activated tension of skinned muscle fibers of the frog. Dependence on magnesium adenosine triphosphate concentration. J Gen Physiol (1974) 3.26

Clinical and biochemical indicators of cardiovascular disease among men living in hard and soft water areas. Lancet (1973) 2.24

Letter: Ischemic heart disease, water hardness and myocardial magnesium. Can Med Assoc J (1975) 2.01

31P NMR studies of intracellular free Mg2+ in intact frog skeletal muscle. J Biol Chem (1980) 2.01

NMR studies of intracellular metal ions in intact cells and tissues. Annu Rev Biophys Bioeng (1984) 1.97

Modulation of cardiac ion channels by magnesium. Annu Rev Physiol (1991) 1.56

Methods for measurement of intracellular magnesium: NMR and fluorescence. Annu Rev Physiol (1991) 1.53

Magnesium gating of the inwardly rectifying K+ channel. Annu Rev Physiol (1991) 1.51

Effects of intracellular free magnesium on calcium current in isolated cardiac myocytes. Science (1988) 1.46

Nucleotide metabolism and cellular damage in myocardial ischemia. Annu Rev Physiol (1985) 1.33

Tension in mechanically disrupted mammalian cardiac cells: effects of magnesium adenosine triphosphate. J Physiol (1977) 1.29

Monitoring cytosolic free magnesium in cultured chicken heart cells by use of the fluorescent indicator Furaptra. Proc Natl Acad Sci U S A (1989) 1.28

Magnesium ions in cardiac function. Regulator of ion channels and second messengers. Biochem Pharmacol (1989) 1.27

Hormonal control of Mg2+ transport in the heart. Nature (1990) 1.26

Hormone receptor modulates the regulatory component of adenylyl cyclase by reducing its requirement for Mg2+ and enhancing its extent of activation by guanine nucleotides. Proc Natl Acad Sci U S A (1982) 1.22

The contribution of intracellular acidosis to the decline of developed pressure in ferret hearts exposed to cyanide. J Physiol (1987) 1.20

Myocardial effects of magnesium. Am J Physiol (1979) 1.11

Role of magnesium in cardiac disease. J Clin Chem Clin Biochem (1983) 1.05

Phosphorous compounds studied by 31P nuclear magnetic resonance spectroscopy in the taenia of guinea-pig caecum. J Physiol (1988) 1.03

Depletion of intracellular free Mg2+ in Mg2(+)- and Ca2(+)-free solution in the taenia isolated from guinea-pig caecum. J Physiol (1990) 0.97

Cellular mechanisms of myocardial stunning. Annu Rev Physiol (1992) 0.95

Intracellular pH modulates cytosolic free magnesium in cultured chicken heart cells. Am J Physiol (1992) 0.89

Changes in intracellular Mg adenosine triphosphate and ionized Mg2+ during blood storage: detection by 31P nuclear magnetic resonance spectroscopy. Blood (1985) 0.88

Effect of inotropic stimulation on cytosolic Mg2+ in isolated rat heart: a 31P magnetic resonance study. Magn Reson Med (1989) 0.87

Cytosolic free magnesium concentration in cultured chick heart cells. Am J Physiol (1989) 0.86

Adenosine formation and energy metabolism: a 31P-NMR study in isolated rat heart. Am J Physiol (1990) 0.81

Magnesium regulation of the beta-receptor-adenylate cyclase complex. I. Effects of manganese on receptor binding and cyclase activation. Mol Pharmacol (1982) 0.79

Articles by these authors

Functional annotation of a full-length mouse cDNA collection. Nature (2001) 23.61

Inhibition of development of Kaposi's sarcoma-related lesions by a bacterial cell wall complex. Science (1992) 6.35

Complete genome structure of the nitrogen-fixing symbiotic bacterium Mesorhizobium loti. DNA Res (2000) 4.94

Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol (1994) 2.74

Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat Immunol (2000) 2.66

Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc (1981) 2.62

Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. Arthritis Rheum (1992) 2.56

Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans: coronary angiographic findings within 1 week before the onset of infarction. Circulation (2000) 2.42

Superoxide anion release by human endothelial cells: synergism between a phorbol ester and a calcium ionophore. J Cell Physiol (1986) 2.26

Cefazolin, a new semisynthetic cephalosporin antibiotic. II. In vitro and in vivo antimicrobial activity. J Antibiot (Tokyo) (1970) 2.20

C-reactive protein is protective against Streptococcus pneumoniae infection in mice. J Exp Med (1981) 2.17

Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17

Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16

Cefazolin, a new semisynthetic cephalosporin antibiotic. 3. Absorption, excretion and tissue distribution in parenteral administration. J Antibiot (Tokyo) (1970) 2.15

Classification and evolution of EF-hand proteins. Biometals (1998) 2.11

In vitro and in vivo evaluation of cefazolin, a new cephalosporin C derivative. Antimicrob Agents Chemother (Bethesda) (1969) 1.96

Studies on denitrification. IX. Nitrous oxide, its production and reduction to nitrogen. J Biochem (1968) 1.93

Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology (2001) 1.91

Isoform-specific localization of voltage-gated K+ channels to distinct lipid raft populations. Targeting of Kv1.5 to caveolae. J Biol Chem (2000) 1.82

Expression of CD7 antigen precludes t(8;21)(q22;q22) chromosome aberration in acute myeloblastic leukemia. Blood (1992) 1.72

Idiopathic polypoidal choroidal vasculopathy in Japanese patients. Arch Ophthalmol (1999) 1.66

Pentoxifylline and intravenous gamma globulin combination therapy for acute Kawasaki disease. Eur J Pediatr (1994) 1.64

Kawasaki disease: A brief history. Pediatrics (2000) 1.63

Radioisotopic studies on renewal of opsin. Vision Res (1968) 1.63

Lipid peroxide level in plasma of diabetic patients. Biochem Med (1979) 1.58

Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate. Arthritis Rheum (1989) 1.56

Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice. Circ Res (2001) 1.56

Peroxisome targeting signal type 1 (PTS1) receptor is involved in import of both PTS1 and PTS2: studies with PEX5-defective CHO cell mutants. Mol Cell Biol (1998) 1.53

Studies on denitrification. 8. Some properties of the N2O-anaerobically grown cell. J Biochem (1971) 1.52

Glutamate dehydrogenase from Escherichia coli: purification and properties. J Bacteriol (1975) 1.51

The features of causes of death in Japanese diabetics during the period 1971-1980. Tohoku J Exp Med (1983) 1.48

yst gene expression in Yersinia enterocolitica is positively regulated by a chromosomal region that is highly homologous to Escherichia coli host factor 1 gene (hfq). Mol Microbiol (1995) 1.48

IgG heavy chain allotypes (Gm) in autoimmune diseases. Clin Exp Immunol (1980) 1.46

Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol (1986) 1.46

Pancreatic ductal adenocarcinoma associated with Potter type III cystic disease. J Gastroenterol (2001) 1.44

Simultaneous or delayed administration of hepatocyte growth factor equally represses the fibrotic changes in murine lung injury induced by bleomycin. A morphologic study. Am J Respir Crit Care Med (1997) 1.43

Elevated levels of pro-inflammatory cytokines in coronary artery thrombi. Int J Cardiol (1999) 1.43

Circadian blood pressure variation in diabetic patients with autonomic neuropathy. J Hypertens (1993) 1.43

Bicyclomycin, a new antibiotic. 3. In vitro and in vivo antimicrobial activity. J Antibiot (Tokyo) (1972) 1.42

Suitability of colchicine and superoxide dismutase for the suppression of renal scarring following an infection with bacteria showing mannose-sensitive pili. Nephron (1990) 1.41

Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J Viral Hepat (2006) 1.39

Neither adrenergic nor cholinergic antagonists in the central nervous system affect 2-deoxy-D-glucose(2-DG)-induced hyperglycemia. Brain Res (1990) 1.39

Effects of antihypertensive agents on circadian blood pressure in hypertensive patients with previous brain infarction. J Hum Hypertens (1997) 1.39

Superantigens and Kawasaki disease. Immunol Today (1991) 1.39

[Effect of percutaneous transvenous mitral commissurotomy for the preservation of sinus rhythm in patients with mitral stenosis]. J Cardiol (2001) 1.39

Psoas abscess and cellulitis of the right gluteal region resulting from carcinoma of the cecum. J Gastroenterol (2001) 1.38

Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol (1988) 1.35

Modulation by copper of the products of nitrite respiration in Pseudomonas perfectomarinus. J Bacteriol (1982) 1.34

Digestive enzymes in insectivorous plants. IV. Enzymatic digestion of insects by Nepenthes secretion and Drosera peltata extract: proteolytic and chitinolytic activities. J Biochem (1972) 1.33

A nitrite reductase from Achromobacter cycloclastes. J Biochem (1972) 1.31

Mammographic density and the risk of breast cancer in Japanese women. Br J Cancer (2005) 1.30

Enzymatic steps of dissimilatory nitrite reduction in Alcaligenes faecalis. J Biochem (1971) 1.30

A possible role of protein kinase C in signal-induced lysosomal enzyme release. Biochem Biophys Res Commun (1983) 1.27

Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells. Antimicrob Agents Chemother (2001) 1.26

Inhibitory action of guanosine 3', 5'-monophosphate on thrombin-induced phosphatidylinositol turnover and protein phosphorylation in human platelets. Biochem Biophys Res Commun (1981) 1.25

Microsurgical anatomy of the lower cervical spine and cord. Neurosurgery (1994) 1.24

Quantitative determination of cytochrome P-450 in rat liver homogenate. Anal Biochem (1976) 1.24

Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study. Diabetes Care (2001) 1.24

Distribution of interleukin-6 in normal and diseased human kidney. Lab Invest (1991) 1.24

Inhibition of human endothelial cell proliferation by gold compounds. J Clin Invest (1987) 1.22

The primary structure of skeletal muscle myosin heavy chain: IV. Sequence of the rod, and the complete 1,938-residue sequence of the heavy chain. J Biochem (1991) 1.22

Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. Genes Immun (2005) 1.21

Temperature dependence of cytochrome P-450 reduction. A model for NADPH-cytochrome P-450 reductase:cytochrome P-450 interaction. J Biol Chem (1976) 1.20

Localized, aggregative, and diffuse adherence to HeLa cells, plastic, and human small intestines by Escherichia coli isolated from patients with diarrhea. J Infect Dis (1992) 1.20

Complete genome structure of the nitrogen-fixing symbiotic bacterium Mesorhizobium loti (supplement). DNA Res (2000) 1.17

Cytochrome b558, a component of the phagocyte NADPH oxidase, is a flavoprotein. Biochem Biophys Res Commun (1992) 1.16

Cardiac metastasis from squamous cell carcinoma of gallbladder. J Gastroenterol (1997) 1.15

Soft-tissue sarcoma mimicking large haematoma: a report of two cases and review of the literature. J Orthop Surg (Hong Kong) (2006) 1.15

Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg (2001) 1.13

Opsonic properties of C-reactive protein in vivo. J Immunol (1982) 1.13

Communication about the ending of anticancer treatment and transition to palliative care. Ann Oncol (2004) 1.13

Serum soluble CD4 and CD8 levels in Kawasaki disease. Clin Exp Immunol (1991) 1.12

The Y chromosome in the liverwort Marchantia polymorpha has accumulated unique repeat sequences harboring a male-specific gene. Proc Natl Acad Sci U S A (2001) 1.10

C-reactive protein reactivity with complement and effects on phagocytosis. Ann N Y Acad Sci (1982) 1.10

Cytochrome c-557 (551) and cytochrome cd of Alcaligenes faecalis. J Biochem (1971) 1.10

Cefazolin, a new semisynthetic cephalosporin antibiotic. VI. Excretion and metabolism of cefazolin- 14 C in rats after intramuscular administration. J Antibiot (Tokyo) (1972) 1.10

Determination of the specific activity of CDK1 and CDK2 as a novel prognostic indicator for early breast cancer. Ann Oncol (2007) 1.10

A comparison of several hypertonic solutions for resuscitation of bled sheep. J Surg Res (1985) 1.09

Intra-articular injection of hyaluronate (SI-6601D) improves joint pain and synovial fluid prostaglandin E2 levels in rheumatoid arthritis: a multicenter clinical trial. Clin Exp Rheumatol (2001) 1.09

Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. Diabetologia (2009) 1.08

Lymphocyte cytotoxicity against Chang liver cells in chronic active hepatitis. Cell Immunol (1978) 1.08

Paradoxical pleural response to antituberculous chemotherapy and isoniazid-induced lupus. Review and report of two cases. Respiration (1998) 1.07

Process of progression of coronary artery lesions from mild or moderate stenosis to moderate or severe stenosis: A study based on four serial coronary arteriograms per year. Circulation (1999) 1.05

Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus. Biochem Biophys Res Commun (1992) 1.05

The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy. Am J Gastroenterol (1994) 1.05

Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB. Brain Res (2000) 1.05

Small-volume resuscitation with hypertonic saline (2,400 mOsm/liter) during hemorrhagic shock. Circ Shock (1984) 1.05

Infusion of very hypertonic saline to bled rats: membrane potentials and fluid shifts. J Surg Res (1985) 1.03

Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator. Biochem Pharmacol (1978) 1.03

Nitric oxide-reducing activity of Alcaligenes faecalis cytochrome cd. J Biochem (1972) 1.03

Basement membrane thickening of postcapillary venules and capillaries in rheumatoid synovium. Immunoelectron microscopic and electron microscopic morphometric analysis. Arthritis Rheum (1987) 1.03

Membrane phospholipid turnover, receptor function and protein phosphorylation. Prog Brain Res (1982) 1.03

Allelotype study of esophageal carcinoma. Genes Chromosomes Cancer (1994) 1.03

A mechanism of cisplatin action: antineoplastic effect through inhibition of neovascularization. Kobe J Med Sci (1997) 1.03

Syngeneic monoclonal antibody against melanoma antigen with interspecies cross-reactivity recognizes GM3, a prominent ganglioside of B16 melanoma. J Biol Chem (1985) 1.03

Thoracic spinal angiomyolipoma with extracanal extension to the thoracic cavity. A case report. Spine (Phila Pa 1976) (1998) 1.02

The participation of cytochromes in the reduction of N20 to N2 by a denitryfying bacterium. J Biochem (1975) 1.02

A new traction device for facilitating endoscopic submucosal dissection (ESD) for early gastric cancer: the "medical ring". Endoscopy (2011) 1.02

The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infection. Clin Exp Immunol (1983) 1.02